Trial Activated for Enrollment

The following study has been recently activated for patient enrollment by the Cancer Center Clinical Trials Office (CTO). Please click on the study link below to be taken to details regarding the study on

Study Title: RiMO-301- Phase I Dose-Escalating Study of RiMO-301 With Radiation in Advanced Tumors

PI: Lawrence Feldman, MD

Sponsor: Coordination Pharmaceuticals, Inc.

For more information or questions about a study, please email [email protected] or call 312-355-5112.

Translate »